Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration

Ferritin elevation has been reported by some laboratories to occur within the substantia nigra (SN), the area of the brain affected in Parkinson's disease (PD), but whether such an increase could be causatively involved in neurodegeneration associated with the disorder is unknown. Here, we report that chronic ferritin elevation in midbrain dopamine-containing neurons results in a progressive age-related neurodegeneration of these cells. This provides strong evidence that chronic ferritin overload could be directly involved in age-related neurodegeneration such as occurs in Parkinson's and other related diseases.

[1]  William Slikker,et al.  Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration , 1997, Brain Research.

[2]  J. Andersen,et al.  Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration , 2005, Journal of neurochemistry.

[3]  K. Jellinger,et al.  Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease. , 1996, Biochimica et biophysica acta.

[4]  C. Morris,et al.  Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease , 2001, Nature Genetics.

[5]  J. Andersen,et al.  Inhibition of Caspases Protects Cerebellar Granule Cells of the Weaver Mouse from Apoptosis and Improves Behavioral Phenotype* , 2002, The Journal of Biological Chemistry.

[6]  Kazuhiro Iwai,et al.  Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice , 2001, Nature Genetics.

[7]  K. Jellinger,et al.  The role of transition metals in the pathogenesis of Parkinson's disease , 1995, Journal of the Neurological Sciences.

[8]  C. Winterbourn,et al.  6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. , 1989, Biochemical pharmacology.

[9]  L. Schmued,et al.  Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration , 2000, Brain Research.

[10]  C. Morris,et al.  Neuroferritinopathy: a window on the role of iron in neurodegeneration. , 2002, Blood cells, molecules & diseases.

[11]  E. Hirsch,et al.  Lack of up‐regulation of ferritin is associated with sustained iron regulatory protein‐1 binding activity in the substantia nigra of patients with Parkinson's disease , 2002, Journal of neurochemistry.

[12]  G. Bartzokis,et al.  Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases , 2004 .

[13]  P D Griffiths,et al.  Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.

[14]  P. Arosio,et al.  Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation. , 2005, Best practice & research. Clinical haematology.

[15]  Rabi Tawil,et al.  Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. , 2005, Journal of neuropathology and experimental neurology.

[16]  R M Henkelman,et al.  MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. , 1993, AJNR. American journal of neuroradiology.

[17]  O. Rascol,et al.  Intracellular Ferritin Accumulation in Neural and Extraneural Tissue Characterizes a Neurodegenerative Disease Associated with a Mutation in the Ferritin Light Polypeptide Gene , 2004, Journal of neuropathology and experimental neurology.

[18]  Peter Riederer,et al.  Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.

[19]  C. Marsden,et al.  Complex I, Iron, and ferritin in Parkinson's disease substantia nigra , 1994, Annals of neurology.

[20]  J. Connor,et al.  A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains , 1995, Journal of neurochemistry.

[21]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.

[22]  M. Hentze,et al.  Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). , 2005, Blood.

[23]  S. Aust,et al.  Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls. , 1986, The Journal of biological chemistry.

[24]  P. Riederer,et al.  In Vitro Studies of Ferritin Iron Release and Neurotoxicity , 1998, Journal of neurochemistry.

[25]  B. Jortner,et al.  Severity of Neurodegeneration Correlates with Compromise of Iron Metabolism in Mice with Iron Regulatory Protein Deficiencies , 2004, Annals of the New York Academy of Sciences.

[26]  Subramanian Rajagopalan,et al.  Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.